Answers are grounded in this paper and cite their sources.
Purpose : The emergence of DNA chip technology has dramatically increased the number genes that can be studied simultaneously. It has afforded toxicologists the opportunity to study thousands of genes at the same time. Affymetrix DNA Microarray analyses were used to assess hepatic gene expression patterns in Male Fisher 344 rats exposed to 0ppm, 50ppm and 500ppm lead (as acetate). Methods : Total RNA was isolated and used for cDNA synthesis, as a template for T7 polymerase in the synthesis of cRNA molecules. These cRNA molecules were cleaned up, fragmented and hybridized to GeneChip® Rat Expression Array Set 230 (RAE 230A) and subsequently scanned as described in Affymetrix GeneChipTM one-cycle eukaryotic target labeling assay. Results : The scatterplot data suggest a greater number of genes were differentially expressed in the 90 days 500 ppm Pb treatment than the other dose groups. Interestingly, 90 days 50 ppm treatment showed less than half the number of genes expressed compared to the 30 days treatment. In contrast, the 90 days 500 ppm group had over one thousand genes differentially expressed at 2-fold and more than twice the number of genes of the other treatment groups at 3-, 5-, and 10-fold levels. Gene precursors for proteins such as FBJ murine osteosarcoma viral oncogene homolog, heat shock protein, protein kinase and proliferating cell nuclear antigen were ten fold up/down-regulated. Conclusion : In summary, effects associated with lead exposure are dose and time dependent. Response to lead poisoning was observed to be almost similar for the short term treatment period irrespective of lead dose levels. However, when the dose levels were low over long periods of time, toxic effects are minimized due to adaptive response over time. On the contrary, lead exposure for long periods of time results in adverse effects in the form of increase incidence of lead-induced gene expression. Support by EPA grant #XP97528301-0 INTRODUCTION TO STUDY The importance of lead as an environmental chemical species exhibiting various toxicity symptoms has been well documented. [1-4]. Lead targets diverse organ systems such as the skeletal, hematopoeitic, renal, endocrine and nervous systems [5], thereby partitioning between soft and hard tissues with approximately 95 % and 70 %, respectively, found in the bones and teeth of adults and children. Bone then serves as a pool to replenish excreted lead from the blood. Some adverse conditions associated with lead poisoning include DNA damage, neurological impairment, abnormal heart function, osteoporosis among others [6-7]. In addition, weakened immune defense system, sterility in male and females, abnormal fetal development, and glycosuria are also associated with chronic lead poison. Lead perturbs the functions of enzymes and proteins of varying types. Studies have shown that, lead exerts its influence physiologically and biochemically as a mimetic agent for essential elements such as calcium, iron and zinc. For instance, it directly interferes with zinc and iron in the biosynthesis of heme, Pb binds to sulfhydryl group protein enzymes and thus interferes with protein synthesis either directly or indirectly [6-7]. Lead binds to different classes of transport proteins including metallothionein, transferin, calmodulin and calcium-ATPase. By associating with these Elevated and Prolonged Lead Exposure in Fisher 344 Rats Leads to Marked Hepatic Differentially Expressed Genes 2 of 13 proteins, it is transported to specific target tissues where it causes its damage. Lead transport and assimilation is optimum when there is the deficiency of iron, calcium, or zinc because lead is able to displace these metals during specific physiologic processes [8]. The interaction of lead and calcium alters the proper functioning of calcium channels and ionic pumps. This leads to inadequate energy generation because of mitochondrial damage. Lead also causes defects in protein folding because of its binding to sulfhyryl groups and it can alter the structure of DNA binding motifs by disrupting their conformation [9]. Recently toxicologists have employed molecular tools such as microarrays in the assessment of risk to humans using different animal models. These molecular tools involve the measurement of so-called expression biomarkers. Biomarker levels in an organism can provide evidence of contaminant bioavailability (if organism is still in the natural environment), exposure and also a variety of possible effects. Biomarkers can include such parameters as protein levels or activity in cells or enzyme activity in a specific tissue and more recently, the expression of relevant and specific genes. Until recently, gene expression analysis was limited to the analysis of one gene at a time. The emergence of DNA chip technology has dramatically increased the number of genes that can now be studied simultaneously. Gene chips have afforded toxicologists the opportunity to study thousands of genes at the same time thus enabling them to examine entire metabolic or signaling pathways and associated transcription factors with target genes [10]. The primary objective of this project is to analyze and assess hepatic gene expression patterns in Fisher 344 rat liver exposed to lead (Pb) at different doses and over different time periods of exposure using Affymetrix Microarray Analysis. Lead can alter the function or activity of genes. For instance Korashy and El-Kadi [11] reported the induction of Cyp1a1 gene expression as a response Pb and other metals. This process they attributed to an AhR-dependent process via transcriptional and post-translational mechanisms. Other workers attribute the dysregulation of genes by lead to feedback mechanisms involving interference of Pb with calcium-binding proteins or perturbation of the activity of protein kinase C (PKC) which in turn alters the transcriptional regulation of mRNA transcripts regulated by PKC [12-13]. Gene expression analysis of a specific gene provides an estimate of the number of mRNA molecules obtained from DNA transcription of that particular gene in response to a stimulus. The assay process involves mRNA isolation from an organism’s tissues, and the mRNA transcripts are then converted to labeled polynucleotides which are placed on microarraysand hybridized with the complimentary sequence tags on the chip. Affymetrix Microarray employs a highdensity oligonucleotide arrays that are fabricated using insilico synthesis of short oligonucleotide sequences on small glass chip by light-directed synthesis. Represented on the chip are known genes or potentially expressed sequences of 11-20 unique oligomeric probes which are 25 bases in length for each gene at different loci on the chip. The target sequence is a group of probes that correspond to a given gene or small group of highly similar genes. Targets are usually labeled enabling them to bind by hybridization to the probes on arrays with which they share sufficient complementary sequence [14]. Gene chip DNA microarray provides a rapid means of quantifying the level of messenger RNA (mRNA) abundance in a tissue sample. Quantified mRNA content is an indication of gene expression levels because mRNA is directly transcribed from the DNA [15]. DNA microarray or “chip” consists of an orderly arrangement of equidistant microscopic DNA spots that are attached to a solid surface like glass or plastic or silicon chip. This chip is made up of thousand of distinct sequences referred to as “probes” found in defined locations on a grid. Complementary DNAs (cDNAs), oligonucleotides of varying length or genomic sequences that are fluorescently or radioactively labeled is hybridized to corresponding probes that recognize and attach to the solid support [15,16]. Subsequently, an array consisting of thousands of immobilized spots at predetermined grid locations is generated via pins or inkjet technology or in situ photolithographic synthesis of oligonucleotides [15-19]. The basic premise is that, nucleic acids molecules show a highly selective binding to their complementary sequences. As a result, the addition of the “target” (pool of mRNAs in the sample-derived nucleic acid sample) to the chip surface leads to a highly parallel searching and sorting of molecular partners, that is, probes linking with their respective complementary targets and this selection process is made quantitative through the presence of millions of identical probes at each single location on the array. A fluorescent-based detection scheme is then employed to quantify mRNA transcript level. This typically Elevated and Prolonged Lead Exposure in Fisher 344 Rats Leads to Marked Hepatic Differentially Expressed Genes 3 of 13 involves the excitation of fluorescent-labeled mRNA molecules with a laser. The fluorescence emission is digitized with a fluorescence scanner and the intensity data is subsequently transferred to a computer-linked database [14-16]. The goal of this study is to analyze the gene expression of Fisher 344 male rat liver due to exposure of Pb by scatterplot. Six weeks post-weaning male rats were given 0 ppm, 50 ppm and 500 ppm Pb as lead acetate for two time points. At the end of each treatment period, gene expression was analyzed as described in Affymetrix GeneChipTM onecycle eukaryotic target labeling assay.
No takes yet. Share an insight, caveat, or question.
A 2010 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: